Medication info

Empagliflozin 25 mg tablet

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Gujoo Pharmaceutical Co., Ltd.
Appearance
Pale yellow, double-convex, oval, film-coated tablet
Packaging
10 tablets/box [10 tablets/PTP x 1], 30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 202102085 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited.

Ingredients

Manufacturer
Gujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty controlling blood sugar
  • cardiovascular disease
  • occurrence of cardiovascular events
View approved original text

This medication is used as an adjunct to diet and exercise to help control blood sugar in adult patients with type 2 diabetes. It can be administered alone, but if blood sugar control is difficult with monotherapy, it can be used in combination with other diabetes medications such as metformin. Additionally, it can be used alongside metformin and pioglitazone, sulfonylurea, or insulin therapy when blood sugar control is challenging. Caution is needed when prescribing this medication to patients with cardiovascular diseases and detailed clinical trial information should be referred to in professional materials. This medication helps improve blood sugar control, assisting in the management of diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited.

Precautions

This medication should not be used in patients who are allergic to the active ingredient or its components. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired kidney function, namely those with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2 or those with end-stage renal disease or on dialysis, should not receive this medication. This medication contains lactose; therefore, patients with genetic conditions such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not use it. In patients with mildly impaired kidney function, the dosage of this medication should be adjusted or discontinued, and regular monitoring of kidney function is essential. In patients with mild to moderate heart failure, caution should be exercised when using this medication, and it is not recommended for patients with severe heart failure. When used with insulin or insulin secretagogues, there is a risk of hypoglycemia, and the dosages of these medications may need to be reduced. Patients should be aware that side effects such as hypoglycemia, urinary tract infections, genital infections, increased urination, and decreased fluid volume may occur while taking this medication. Particularly, severe metabolic acidosis known as ketoacidosis can occur, and immediate treatment should be sought if symptoms arise. Elderly patients or those at risk of fluid volume loss should be cautious as dehydration or hypotension may occur. Additionally, this medication may rarely cause serious infections such as genital necrosis; thus, if pain or swelling occurs around the genital area, medical personnel should be notified immediately. It is recommended that pregnant or breastfeeding women do not use this medication, and if pregnancy is confirmed, cessation of treatment should occur. The safety and efficacy in children under 18 years of age have not been established. In case of overdose, appropriate treatment should be initiated based on clinical conditions, and this medication may increase urine output. This medication may interact with other drugs, so if other medications are being taken, healthcare providers should be informed. Caution is necessary while driving or operating machinery due to the risk of hypoglycemia. Regular monitoring of kidney function and blood sugar levels is important while on this medication.

Side effects

  • Hypoglycemia
  • vulvodynia
  • vulvitis
  • balanitis
  • other genital infections
  • increased urination
  • urinary difficulty
  • interstitial nephritis
  • itching
  • rash
Show 215 more
  • urticaria
  • angioedema
  • decreased fluid volume
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcers
  • colitis
  • vomiting
  • ischemic colitis
  • colonic bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • traction retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • cavities
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyp
  • gingival edema
  • blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • nasopharyngitis
  • positional vertigo
  • sensory impairment
  • perceptual disturbances
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • abnormal sensations
  • swelling
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive urine red blood cells
  • hematuria
  • hyperactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • acanthosis nigricans
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • eye discomfort
  • conjunctival injection
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorder
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes mellitus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

Pale yellow, double-convex, oval, film-coated tablet

Package unit

10 tablets/box [10 tablets/PTP x 1], 30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.